Company Filing History:
Years Active: 2025
Title: Bette Monnot-Chase: Innovator in Citrulline Synthesis
Introduction
Bette Monnot-Chase is a notable inventor based in Baltimore, MD (US). She has made significant contributions to the field of biochemistry, particularly in the synthesis and purification of citrulline. Her innovative work has implications for various applications in pharmaceuticals and nutrition.
Latest Patents
Bette Monnot-Chase holds a patent for a method of synthesis and purification of citrulline. This invention provides a novel approach for synthesizing citrulline from a transition metal complex of ornithine using cyanate to derivatize the terminal amino group of ornithine. Additionally, her patent outlines improved methods for purifying citrulline produced by the reaction of cyanate with ornithine. The purification process includes steps such as reprecipitation of the copper complex of citrulline, removal of the complexing metal through sulfide precipitation, activated carbon adsorption, and antisolvent crystallization. She has 1 patent to her name.
Career Highlights
Bette Monnot-Chase is currently associated with Asklepion Pharmaceuticals, LLC, where she continues to advance her research and development efforts. Her work is pivotal in enhancing the understanding and production of citrulline, which is essential for various biological processes.
Collaborations
Bette has collaborated with esteemed colleagues, including James Alan Bull and Holger Christian Fischer. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.
Conclusion
Bette Monnot-Chase is a pioneering inventor whose work in the synthesis and purification of citrulline has made a significant impact in her field. Her contributions continue to influence advancements in biochemistry and pharmaceuticals.